Extract from the Register of European Patents

EP About this file: EP1032708

EP1032708 - NUCLEIC ACID LIGANDS OF TISSUE TARGET [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.09.2005
Database last updated on 21.03.2026
Most recent event   Tooltip17.10.2008Change - representativepublished on 19.11.2008  [2008/47]
Applicant(s)For all designated states
Schering Aktiengesellschaft
Müllerstrasse 170/178
13353 Berlin / DE
[N/P]
Former [2001/21]For all designated states
SCHERING AKTIENGESELLSCHAFT
Müllerstrasse 170/178
13353 Berlin / DE
Former [2000/36]For all designated states
NeXstar Pharmaceuticals, Inc.
2860 Wilderness Place, Suite 200, Englewood
Boulder, CO 80301 / US
For all designated states
Schering Aktiengesellschaft
Müllerstrasse 170-172e
1000 Berlin 65 / DE
Inventor(s)01 / STEPHENS, Andrew
740 Kelly Road West
Boulder, CO 80302 / US
02 / GOLD, Larry
1033 5th Street
Boulder, CO 80302 / US
03 / SPECK, Ulrich
Fürstendamm 20
D-13465 Berlin / DE
[2000/36]
Representative(s)Dörries, Hans Ulrich, et al
df-mp Patentanwälte Rechtsanwälte PartG mbB
Theatinerstraße 16
80333 München / DE
[N/P]
Former [2008/47]Dörries, Hans Ulrich, et al
df-mp Fünf Höfe Theatinerstrasse 16
80333 München / DE
Former [2001/12]Dörries, Hans Ulrich, Dr., et al
Dörries Frank-Molnia Pohlman Postfach 22 16 61
80506 München / DE
Former [2000/36]Dörries, Hans Ulrich, et al
Frohwitter Patent- und Rechtsanwälte Possartstrasse 20
81679 München / DE
Application number, filing date98960403.819.11.1998
[2000/36]
WO1998US25006
Priority number, dateUS1997097641321.11.1997         Original published format: US 976413
[2000/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9927138
Date:03.06.1999
Language:EN
[1999/22]
Type: A1 Application with search report 
No.:EP1032708
Date:06.09.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 03.06.1999 takes the place of the publication of the European patent application.
[2000/36]
Search report(s)International search report - published on:US03.06.1999
(Supplementary) European search report - dispatched on:EP30.07.2004
ClassificationIPC:C12P19/34, C12Q1/68, C07H21/00
[2004/29]
CPC:
G01N33/76 (EP,US); A61K47/547 (EP,US); A61K47/549 (EP,US);
B82Y5/00 (EP,US); C07H19/06 (EP,US); C07H19/10 (EP,US);
C07H21/00 (EP,US); C07K14/001 (EP,US); C07K14/005 (EP,US);
C07K14/72 (EP,US); C07K7/22 (EP,US); C12N15/1048 (EP,US);
C12N15/115 (EP,US); C12N9/1276 (EP,US); C12Q1/37 (EP,US);
G01N33/53 (EP,US); G01N33/531 (EP,US); G01N33/532 (EP,US);
G01N33/535 (EP,US); G01N33/56988 (EP,US); G01N33/68 (EP,US);
A61K38/00 (EP,US); C12N2310/13 (EP,US); C12N2310/16 (EP,US);
C12N2310/321 (EP,US); C12N2310/322 (EP,US); C12N2310/344 (EP,US);
C12N2310/53 (EP,US); C12N2740/16222 (EP,US); C40B40/00 (EP,US);
F02B2075/027 (EP,US); G01N2333/16 (EP,US); G01N2333/163 (EP,US);
G01N2333/4724 (EP,US); G01N2333/503 (EP,US); G01N2333/575 (EP,US);
G01N2333/62 (EP,US); G01N2333/7056 (EP,US); G01N2333/8125 (EP,US);
G01N2333/96433 (EP,US); G01N2333/96436 (EP,US); G01N2333/96455 (EP,US);
G01N2333/96486 (EP,US); G01N2333/966 (EP,US); G01N2333/9726 (EP,US);
G01N2333/974 (EP,US); G01N2333/976 (EP,US) (-)
Former IPC [2000/36]C12Q1/68, C12P19/34, C07H21/02, C07H21/04
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/36]
Extension statesAL18.05.2000
LT18.05.2000
LV18.05.2000
MK18.05.2000
RO18.05.2000
SI18.05.2000
TitleGerman:NUKLEINSÄURELIGANDEN FÜR ZIELGEWEBE[2000/36]
English:NUCLEIC ACID LIGANDS OF TISSUE TARGET[2000/36]
French:LIGANDS D'ACIDE NUCLEIQUE DE CIBLE TISSULAIRE[2000/36]
Entry into regional phase18.05.2000National basic fee paid 
18.05.2000Search fee paid 
18.05.2000Designation fee(s) paid 
18.05.2000Examination fee paid 
Examination procedure18.05.1999Request for preliminary examination filed
International Preliminary Examining Authority: US
18.05.2000Examination requested  [2000/36]
22.09.2004Despatch of a communication from the examining division (Time limit: M06)
05.04.2005Application deemed to be withdrawn, date of legal effect  [2005/45]
10.05.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2005/45]
Fees paidRenewal fee
16.10.2000Renewal fee patent year 03
22.10.2001Renewal fee patent year 04
18.10.2002Renewal fee patent year 05
16.10.2003Renewal fee patent year 06
19.10.2004Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]   JELLINEK D ET AL: "INHIBITION OF RECEPTOR BINDING BY HIGH-AFFINITY RNA LIGANDS TO VASCULAR ENDOTHELIAL GROWTH FACTOR", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 34, no. 33, 30 August 1994 (1994-08-30), pages 10450 - 10456, XP001084739, ISSN: 0006-2960 [A] 1 * the whole document *

DOI:   http://dx.doi.org/10.1021/bi00200a028
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.